scholarly journals Bright Pink Assess Your Risk™: a novel interactive tool for breast and ovarian cancer risk assessment (Preprint)

10.2196/29124 ◽  
2021 ◽  
Author(s):  
Elizabeth A Hibler ◽  
Angela J Fought ◽  
Kiarri N Kershaw ◽  
Rebecca Molsberry ◽  
Virginia Nowakowski ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk ◽  
Breast And Ovarian Cancer ◽  
Interactive Tool ◽  
Bright Pink

Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 1513-1513
Author(s):  
Leif W. Ellisen ◽  
Allison W. Kurian ◽  
Andrea J Desmond ◽  
Meredith Mills ◽  
Stephen E Lincoln ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Clinical Impact ◽  
Gene Panel ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk ◽  
Breast And Ovarian Cancer ◽  
Panel Testing ◽  
Gene Panel Testing

scholarly journals Hereditary breast and ovarian cancer: risk assessment in minority women and provider knowledge gaps

2016 ◽  
Vol 14 (6) ◽  
pp. 261-267 ◽  
Author(s):  
Nancy Paris ◽  
Sheryl Gabram-Mendola ◽  
Alice Kerber ◽  
Jean O'Connor ◽  
Barbara Crane ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Minority Women ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk ◽  
Breast And Ovarian Cancer ◽  
Knowledge Gaps ◽  
Provider Knowledge

scholarly journals Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

JAMA Oncology ◽  
2015 ◽  
Vol 1 (7) ◽  
pp. 943 ◽  
Author(s):  
Andrea Desmond ◽  
Allison W. Kurian ◽  
Michele Gabree ◽  
Meredith A. Mills ◽  
Michael J. Anderson ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk ◽  
Breast And Ovarian Cancer ◽  
Panel Testing ◽  
Multigene Panel Testing ◽  
Multigene Panel

Bright Pink Assess Your Risk™: a novel interactive tool for breast and ovarian cancer prevention (Preprint)

2021 ◽  
Author(s):  
Elizabeth A Hibler ◽  
Angela J Fought ◽  
Kiarri N Kershaw ◽  
Rebecca Molsberry ◽  
Virginia Nowakowski ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Family History ◽  
Cancer Risk ◽  
Ovarian Cancer Risk ◽  
Age Group ◽  
Breast And Ovarian Cancer ◽  
Nccn Guidelines ◽  
Bright Pink ◽  
Race Ethnicity

BACKGROUND The lifetime risk of breast and ovarian cancer is significantly higher among women with genetic susceptibility or strong family history. However, current practices may identify only 10% of asymptomatic carriers of susceptibility genes. Bright Pink developed the Assess Your Risk (AYR) tool to estimate breast and ovarian cancer risk through a user-friendly, informative online quiz. OBJECTIVE The objectives of this work are to present the AYR tool, describe the AYR users, and compare classification using the AYR tool to breast and ovarian cancer genetic testing guidelines. METHODS The AYR tool includes 26 questions based on the National Cancer Center Network (NCCN) guidelines and factors from other commonly used risk assessment tools. We included all women who completed AYR between November 2018 and January 2019 with the exception of self-reported cancer or no knowledge of family history. We conducted univariate analyses and compared the AYR tool to NCCN criteria using measures of validity along with McNemar's Test. RESULTS There were 143,657 AYR completions, and most participants were either at increased or average risk for breast cancer or ovarian cancer (95.6%). Using the NCCN guidelines as the gold standard, the estimated sensitivity and specificity for the AYR was 100% and 89.9%, respectively (McNemar’s p= <0.001). Specificity improved when considering the additional questions asked by the AYR. However, we did observe some variation by race-ethnicity and age group. We found the lowest observed specificity was for Asian race (85.9%) and the 30-39 year age group (87.6%) for the AYR compared to NCCN criteria. CONCLUSIONS These results demonstrate that Bright Pink’s AYR is an accurate tool for identifying women at increased risk of breast and ovarian cancer. However, future studies should validate the tool longitudinally, considering the variation observed by race-ethnicity and age on breast and ovarian cancer risk assessment.

Ovarian Cancer Risk Assessment

2006 ◽  
Vol 107 (Supplement) ◽  
pp. 11S ◽  
Author(s):  
Deborah A. Ronco ◽  
John P. Geisler ◽  
K J. Manahan
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk

Genetic cancer risk assessment: A screenshot of the psychosocial profile of women at risk for hereditary breast and ovarian cancer syndrome

2020 ◽  
Vol 29 (4) ◽  
pp. 681-687
Author(s):  
Natalia Campacci ◽  
Henrique Campos Reis Galvão ◽  
Lucas F. Garcia ◽  
Paula C. Ribeiro ◽  
Rebeca S. Grasel ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
At Risk ◽  
Cancer Risk ◽  
Cancer Risk Assessment ◽  
Cancer Syndrome ◽  
Breast And Ovarian Cancer ◽  
Psychosocial Profile

Clinical Decision Making Using Ovarian Cancer Risk Assessment

2010 ◽  
Vol 194 (2) ◽  
pp. 337-342 ◽  
Author(s):  
Michael P. Stany ◽  
G. Larry Maxwell ◽  
G. Scott Rose
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Decision Making ◽  
Cancer Risk ◽  
Clinical Decision Making ◽  
Clinical Decision ◽  
Cancer Risk Assessment ◽  
Ovarian Cancer Risk

Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer

2008 ◽  
Vol 17 (8) ◽  
pp. 774-782 ◽  
Author(s):  
Veronica I. Lagos ◽  
Martin A. Perez ◽  
Charité N. Ricker ◽  
Kathleen R. Blazer ◽  
Nydia M. Santiago ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Cancer Risk ◽  
Social Cognitive ◽  
Cancer Risk Assessment ◽  
Breast And Ovarian Cancer

scholarly journals Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

2008 ◽  
Vol 17 (3) ◽  
pp. 173-189 ◽  
Author(s):  
Sandra K. Prucka ◽  
Dawn E. McIlvried ◽  
Bruce R. Korf
Keyword(s):  
Ovarian Cancer ◽  
Risk Assessment ◽  
Genetic Counseling ◽  
Cancer Risk ◽  
Cancer Risk Assessment ◽  
Breast And Ovarian Cancer ◽  
Counseling Process
Sign in / Sign up

Export Citation Format

Share Document